Clinical Diagnostics

In Vitro Diagnostics
We are proceeding with clinical diagnostic (or stand-alone diagnostic)
opportunities. In order to minimize the length of the clinical trial and to
maximize the returns on trial cost, the first clinical diagnostic test that
we develop will be an IVD for use in MCI patient populations who do not
meet current NINCDS criteria. The indication would be for a physician-
administered test for the detection of AD-type dementia risk in MCI patients
and would be aimed at physicians in memory clinics for clinical use.

> RESEARCH KITS

.

.